CM, F., ML, G., & A, O. (2024). Editorial: Unravelling real-world impact of second-line therapies in primary biliary cholangitis-Time to change our targets? Authors' reply. Alimentary pharmacology & therapeutics, 60(1), 91. https://doi.org/10.1111/apt.18048
Chicago Style (17th ed.) CitationCM, Fernández-Rodríguez, Gutierrez ML, and Olveira A. "Editorial: Unravelling Real-world Impact of Second-line Therapies in Primary Biliary Cholangitis-Time to Change Our Targets? Authors' Reply." Alimentary Pharmacology & Therapeutics 60, no. 1 (2024): 91. https://doi.org/10.1111/apt.18048.
MLA (9th ed.) CitationCM, Fernández-Rodríguez, et al. "Editorial: Unravelling Real-world Impact of Second-line Therapies in Primary Biliary Cholangitis-Time to Change Our Targets? Authors' Reply." Alimentary Pharmacology & Therapeutics, vol. 60, no. 1, 2024, p. 91, https://doi.org/10.1111/apt.18048.